KTTA•benzinga•
Pasithea Therapeutics Completes Enrollment And Initial Dosing Of Three Subjects In Cohort 6 With 30 Mg Capsules Of PAS-004
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 29, 2025 by benzinga